0,1
"5.2.7.3	
Alpha 1-blockers + beta-3 agonist
Mechanism of action: Combination therapy consists of an α1-blocker (Section 5.2.1) together with a beta-3-
agonist (Section 5.2.4) as an add-on therapy in males receiving α1-blockers with persisting OAB symptoms.",
Recommendations,Strength rating
"Use combination treatment of a α1-blocker with a muscarinic receptor antagonist in 
patients with moderate-to-severe LUTS if relief of storage symptoms has been insufficient 
with monotherapy with either drug.",Strong
Do not prescribe combination treatment in men with a post-void residual volume > 150 mL.,Weak
